1. Correlation of cytogenetic response with gene expression profiles in chronic myelogenous leukemia patients treated with imatinib (Gleevec™/Glivec®);McLean;American Society of Hematology Annual meeting, 6–10 December 2002, Philadelphia (Abstract No. 2149),2002
2. Pharmacogenomic Analyses of myeloma samples from Bortezomib (Velcade™) Phase II clinical trial;Mulligan;American Society of Hematology Annual meeting, 6–10 December 2002, Philadelphia (Abstract No. 1519),2002
3. Transcriptional profiles in peripheral blood mononuclear cells prognostic of clinical outcomes in patients with advanced renal cell carcinoma;Burczynski;Clin. Cancer Res.,2005